You are here

Article Text

Article menu
Download PDFPDF
Treatment
After 3 months, low dose oral contraceptives reduced pain in adolescent girls with moderate to severe dysmenorrhoea

https://doi.org/10.1136/ebn.9.1.16

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Davis AR, Westhoff C, O’Connell K, et al. Oral contraceptives for dysmenorrhea in adolescent girls: a randomized trial. Obstet Gynecol 2005;106:97–104.OpenUrlCrossRefPubMedWeb of Science

    Q What is the efficacy of low dose oral contraceptives (OCs) for primary dysmenorrhoea in adolescent girls?

    METHODS

    Embedded ImageDesign:

    randomised placebo controlled trial.

    Embedded ImageAllocation:

    unclear concealment.

    Embedded ImageBlinding:

    blinded (patients and healthcare providers).

    Embedded ImageFollow up period:

    3 months.

    Embedded ImageSetting:

    a single academic medical centre in New York, USA.

    Embedded ImagePatients:

    76 healthy adolescent girls ⩽19 years of age (mean age 17 y) who had dysmenorrhoea that was classified using the Robinson modification of the Andersch scale as moderate (sometimes or always experiencing very painful menstrual cramps) or severe (sometimes or always cutting back on activities in addition to experiencing painful menstrual cramps); regular menstrual cycles for ⩾1 year; menstrual cycle length of 21–35 days; and were abstinent or used condoms. Exclusion criteria were need for …

    View Full Text

    Footnotes

    • For correspondence: Dr A R Davis, Columbia University Medical Center, New York, NY, USA. ard4{at}columbia.edu

    • Source of funding: National Institute of Child Health and Human Development; Wyeth Pharmaceuticals provided oral contraceptive and placebo pills.